kras mutation and glutathion glynac The roles of in cancer metabolism, tumor microenvironment clinical therapy Multiple Strategies to Develop Small
Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors KRAS Targeted Therapy Doubles as Component of Immunotherapy NCI KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment The Metabolic Landscape of RAS Driven Cancers from biology to therapy PMC
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



